These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
415 related items for PubMed ID: 17416967
1. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide. Seyb KI, Ansar S, Li G, Bean J, Michaelis ML, Dobrowsky RT. J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967 [Abstract] [Full Text] [Related]
2. Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons. Li G, Faibushevich A, Turunen BJ, Yoon SO, Georg G, Michaelis ML, Dobrowsky RT. J Neurochem; 2003 Jan; 84(2):347-62. PubMed ID: 12558997 [Abstract] [Full Text] [Related]
3. Fuzhisan, a Chinese herbal medicine, inhibits beta-amyloid-induced neurotoxicity and tau phosphorylation through calpain/Cdk5 pathway in cultured cortical neurons. Zhang Z, Zhao R, Tang Y, Wen S, Wang D, Qi J. Neurochem Res; 2011 May; 36(5):801-11. PubMed ID: 21243427 [Abstract] [Full Text] [Related]
5. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. Hallows JL, Chen K, DePinho RA, Vincent I. J Neurosci; 2003 Nov 19; 23(33):10633-44. PubMed ID: 14627648 [Abstract] [Full Text] [Related]
6. Atorvastatin prevents Aβ oligomer-induced neurotoxicity in cultured rat hippocampal neurons by inhibiting Tau cleavage. Sui HJ, Zhang LL, Liu Z, Jin Y. Acta Pharmacol Sin; 2015 May 19; 36(5):553-64. PubMed ID: 25891085 [Abstract] [Full Text] [Related]
7. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies. Lopes JP, Oliveira CR, Agostinho P. Cell Mol Neurobiol; 2007 Nov 19; 27(7):943-57. PubMed ID: 17965932 [Abstract] [Full Text] [Related]
9. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation. Kerokoski P, Suuronen T, Salminen A, Soininen H, Pirttilä T. Biochem Biophys Res Commun; 2002 Nov 15; 298(5):693-8. PubMed ID: 12419309 [Abstract] [Full Text] [Related]
17. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. Wen Y, Planel E, Herman M, Figueroa HY, Wang L, Liu L, Lau LF, Yu WH, Duff KE. J Neurosci; 2008 Mar 05; 28(10):2624-32. PubMed ID: 18322105 [Abstract] [Full Text] [Related]